{"log_id": 1163736397953568570, "direction": 0, "words_result_num": 46, "words_result": [{"probability": {"variance": 0.011707, "average": 0.93453, "min": 0.60688}, "location": {"width": 326, "top": 111, "height": 54, "left": 200}, "words": "核准日期:2007年02月12日"}, {"probability": {"variance": 1e-06, "average": 0.999549, "min": 0.997067}, "location": {"width": 426, "top": 169, "height": 51, "left": 410}, "words": "奥沙利铂注射液说明书"}, {"probability": {"variance": 2e-06, "average": 0.999175, "min": 0.994444}, "location": {"width": 457, "top": 242, "height": 33, "left": 381}, "words": "请仔细阅读说明书并在医师指导下使用"}, {"probability": {"variance": 1e-06, "average": 0.999419, "min": 0.997191}, "location": {"width": 98, "top": 298, "height": 22, "left": 204}, "words": "【药品名称】"}, {"probability": {"variance": 9e-06, "average": 0.998006, "min": 0.989039}, "location": {"width": 212, "top": 328, "height": 23, "left": 234}, "words": "通用名称:奥沙利铂注射液"}, {"probability": {"variance": 5e-06, "average": 0.998658, "min": 0.9935}, "location": {"width": 124, "top": 359, "height": 23, "left": 235}, "words": "商品名称:艾恒"}, {"probability": {"variance": 0.000659, "average": 0.985447, "min": 0.92408}, "location": {"width": 202, "top": 391, "height": 22, "left": 235}, "words": "英文名称: Oxaliplatin Inj"}, {"probability": {"variance": 1e-06, "average": 0.99909, "min": 0.998237}, "location": {"width": 71, "top": 420, "height": 22, "left": 234}, "words": "汉语拼音"}, {"probability": {"variance": 0, "average": 0.7516, "min": 0.7516}, "location": {"width": 17, "top": 424, "height": 16, "left": 400}, "words": " hi"}, {"probability": {"variance": 0.000415, "average": 0.987217, "min": 0.951942}, "location": {"width": 99, "top": 451, "height": 23, "left": 203}, "words": "【成份】"}, {"probability": {"variance": 0.009339, "average": 0.956092, "min": 0.495141}, "location": {"width": 793, "top": 479, "height": 24, "left": 235}, "words": "本品主要成份为奥沙利铂。其化学名称为(1R-反式)-(1,-2环己二胺N,N)[草酸(2-)-O,]合铂"}, {"probability": {"variance": 0, "average": 0.999786, "min": 0.999589}, "location": {"width": 92, "top": 513, "height": 21, "left": 233}, "words": "其结构式为"}, {"probability": {"variance": 0.035984, "average": 0.812108, "min": 0.508737}, "location": {"width": 225, "top": 536, "height": 99, "left": 517}, "words": "∠NH2Pt"}, {"probability": {"variance": 0, "average": 0.990589, "min": 0.990589}, "location": {"width": 47, "top": 639, "height": 30, "left": 540}, "words": " NH"}, {"probability": {"variance": 0, "average": 0.998272, "min": 0.998272}, "location": {"width": 15, "top": 655, "height": 23, "left": 582}, "words": "2"}, {"probability": {"variance": 0.010641, "average": 0.947053, "min": 0.598298}, "location": {"width": 164, "top": 701, "height": 23, "left": 232}, "words": "分子式:CBH14N2O4Pt"}, {"probability": {"variance": 0.006026, "average": 0.967257, "min": 0.74055}, "location": {"width": 121, "top": 733, "height": 21, "left": 232}, "words": "分子量:397.29"}, {"probability": {"variance": 9e-06, "average": 0.997437, "min": 0.991896}, "location": {"width": 120, "top": 764, "height": 23, "left": 235}, "words": "其辅料为甘露醇"}, {"probability": {"variance": 3.2e-05, "average": 0.996074, "min": 0.986263}, "location": {"width": 95, "top": 794, "height": 23, "left": 203}, "words": "【性状】"}, {"probability": {"variance": 2e-06, "average": 0.998527, "min": 0.994964}, "location": {"width": 261, "top": 824, "height": 22, "left": 235}, "words": "本品为无色或几乎无色的澄明液体"}, {"probability": {"variance": 0.000232, "average": 0.986403, "min": 0.957986}, "location": {"width": 139, "top": 853, "height": 25, "left": 202}, "words": "【适应症】"}, {"probability": {"variance": 0.001297, "average": 0.99263, "min": 0.762922}, "location": {"width": 714, "top": 881, "height": 30, "left": 233}, "words": "适用于经过5氟尿嘧啶治疗失败之后的结、直肠癌转移的患者,可单独或联合5-氟尿嘧啶使用"}, {"probability": {"variance": 0.000103, "average": 0.989665, "min": 0.975116}, "location": {"width": 117, "top": 913, "height": 26, "left": 207}, "words": "【规格】"}, {"probability": {"variance": 0, "average": 0.707649, "min": 0.707649}, "location": {"width": 18, "top": 931, "height": 16, "left": 323}, "words": "t"}, {"probability": {"variance": 0.050907, "average": 0.776252, "min": 0.494393}, "location": {"width": 87, "top": 951, "height": 19, "left": 238}, "words": " 100ml: 0.Ig"}, {"probability": {"variance": 0.000116, "average": 0.993211, "min": 0.971786}, "location": {"width": 87, "top": 977, "height": 24, "left": 204}, "words": "【用法用量"}, {"probability": {"variance": 0.001633, "average": 0.9882, "min": 0.721234}, "location": {"width": 805, "top": 1002, "height": 32, "left": 230}, "words": "在单独或联合用药时,推荐剂量为按体表面积一次130mg/m2,静脉输注2~6小时。没有主要毒性出现时,"}, {"probability": {"variance": 0.011398, "average": 0.962528, "min": 0.527352}, "location": {"width": 606, "top": 1036, "height": 28, "left": 198}, "words": "每3周(21天)给药1次。剂量的调整应以安全性,尤其是神经学的安全性为依据"}, {"probability": {"variance": 0, "average": 0.999363, "min": 0.998046}, "location": {"width": 97, "top": 1072, "height": 23, "left": 202}, "words": "【不良反应】"}, {"probability": {"variance": 0.000279, "average": 0.995516, "min": 0.897816}, "location": {"width": 617, "top": 1094, "height": 34, "left": 230}, "words": "1.血液学方面的不良反应主要是:贫血,白细胞减少,粒细胞减少,血小板减少"}, {"probability": {"variance": 0.000157, "average": 0.995892, "min": 0.935663}, "location": {"width": 431, "top": 1128, "height": 29, "left": 231}, "words": "2.非血液学方面的不良反应主要是:恶心、呕吐、腹泻"}, {"probability": {"variance": 0.001425, "average": 0.991452, "min": 0.754492}, "location": {"width": 777, "top": 1156, "height": 31, "left": 230}, "words": "3.神经系统:以末梢神经炎为主要表现,有时可有口腔周围、上呼吸道和上消化道的痉挛及感觉障碍"}, {"probability": {"variance": 5e-06, "average": 0.99838, "min": 0.99475}, "location": {"width": 99, "top": 1193, "height": 23, "left": 202}, "words": "【禁忌】"}, {"probability": {"variance": 2.5e-05, "average": 0.997298, "min": 0.979675}, "location": {"width": 242, "top": 1222, "height": 23, "left": 230}, "words": "1.对铂类衍生物有过敏者禁用"}, {"probability": {"variance": 0.000401, "average": 0.992491, "min": 0.929265}, "location": {"width": 189, "top": 1253, "height": 23, "left": 230}, "words": "2.妊娠及哺乳期间慎用"}, {"probability": {"variance": 0, "average": 0.999655, "min": 0.999257}, "location": {"width": 96, "top": 1287, "height": 20, "left": 203}, "words": "【注意事项】"}, {"probability": {"variance": 6.6e-05, "average": 0.99647, "min": 0.955952}, "location": {"width": 778, "top": 1307, "height": 33, "left": 257}, "words": "奥沙利铂应在具有抗癌化疗经验的医师的监督下使用。特别是与具有潜在性神经毒性的药物联合用药时"}, {"probability": {"variance": 1.1e-05, "average": 0.998248, "min": 0.986399}, "location": {"width": 283, "top": 1346, "height": 24, "left": 197}, "words": "应严密监测奥沙利铂的神经学安全性"}, {"probability": {"variance": 0.005239, "average": 0.978825, "min": 0.670241}, "location": {"width": 317, "top": 1375, "height": 26, "left": 230}, "words": "2.应给予预防性和/或治疗性的止吐用药;"}, {"probability": {"variance": 0.001794, "average": 0.982632, "min": 0.843469}, "location": {"width": 229, "top": 1407, "height": 25, "left": 230}, "words": "3.当出现血液毒性时(白细胞"}, {"probability": {"variance": 0.011638, "average": 0.95465, "min": 0.468808}, "location": {"width": 489, "top": 1400, "height": 30, "left": 496}, "words": "0/mm3或血小板<50000m3),应推迟下一周期用药,直到恢复"}, {"probability": {"variance": 7.3e-05, "average": 0.997665, "min": 0.942875}, "location": {"width": 750, "top": 1429, "height": 35, "left": 257}, "words": "在每一疗程治疗之前应进行血液计数和分类,在治疗开始之前应进行神经学检查,之后应定期进行"}, {"probability": {"variance": 5.4e-05, "average": 0.996118, "min": 0.97065}, "location": {"width": 782, "top": 1460, "height": 34, "left": 263}, "words": "患者在两个疗程之间持续存在疼痛性感觉异常或和功能障碍时,本品用量应减少25%,调整剂量后若症"}, {"probability": {"variance": 0, "average": 0.999414, "min": 0.997736}, "location": {"width": 195, "top": 1502, "height": 23, "left": 197}, "words": "状仍存在或加重,应停药"}, {"probability": {"variance": 1e-06, "average": 0.999234, "min": 0.994756}, "location": {"width": 699, "top": 1523, "height": 32, "left": 265}, "words": "不要与碱性的药物或介质、氯化合物、碱性制剂等一起使用,也不要用含铝的静脉注射器具"}, {"probability": {"variance": 0.00029, "average": 0.993727, "min": 0.911689}, "location": {"width": 475, "top": 1556, "height": 29, "left": 264}, "words": "因使用本品时低温可致痉挛,故不得用冰冷食物或用冰水漱口"}], "language": 3}